1256383-69-3

Upstream product

• 1251195-93-3 (S)-5,5'-(4,4'-oxybis(4,1-phenylene))bis(2-((S)-pyrrolidin-2-yl)-1H-imidazole) 
• 111398-44-8 N-methoxycarbonyl-L-valine 
• 1240427-94-4 (2S,2'S)-tert-butyl 2,2'-(5,5'-(4,4'-oxybis(4,1-phenylene))bis(1H-imidazole-5,2-diyl))dipyrro lidine-1-carboxylate 
• 4073-80-7 bis(p-bromoacetylphenyl) ether 
• 1240427-81-9 (2S,2'S)-1-tert-butyl '2,2-2,2'-(4,4'-oxybis(4,1-phenylene))bis(2-oxo-ethane-2,1-diyl)dipyrrolidine-1,2-dicarboxylate 
• 101-84-8 diphenylether 

Relevant academic research and scientific papers

Synthesis and biological evaluation of new potent and selective HCV NS5A inhibitors

NS5A inhibitors are a new class of direct-acting antiviral agents which display very potent anti-HCV activity in vitro and in humans. Rationally designed modifications to the central biphenyl linkage of a known NS5A series led to selection of several comp

POTENT AND SELECTIVE INHIBITORS OF HEPATITIS C VIRUS

The present invention is directed to compounds, compositions and methods for treating or preventing hepatitis C virus (HCV) infection in human subjects or other animal hosts. The compounds are as also pharmaceutically acceptable, salts, prodrugs, and othe